Grade 2 Chondrosarcoma Treated by Intralesional Curettage: Follow-up vs Resection

NCT06714773 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 62

Last updated 2024-12-04

No results posted yet for this study

Summary

The goal of this observational study is to assess the oncological outcomes in patients diagnosed with grade 2 chondrosarcoma, treated with intralesional curettage, stratified into two cohorts: those subjected to follow up monitoring and those who have undergone subsequent surgical intervention.

Conditions

  • Chondrosarcoma, Grade 2

Sponsors & Collaborators

  • IRCCS Azienda Ospedaliero-Universitaria di Bologna

    lead OTHER

Principal Investigators

  • Andrea Sambri, MD · IRCCS Azienda Ospedaliero-Universitaria di Bologna

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-20
Primary Completion
2024-07-20
Completion
2024-08-01

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06714773 on ClinicalTrials.gov